Cancer stem cells that survive after a tumor is treated go on to form new tumors that do not respond to further treatment.

A research team at Lund University in Sweden has discovered a certain type of cell—foam cells—in patients with the aggressive ...

Targeting and customizing blood vessels in tumors to increase T cell infiltration and maintain their function may represent the next breakthrough in cancer therapy.

Trevor Reese is 26 years old and is battling Glioblastoma brain cancer. Reese and his family learned about ... The treatment ...

Announced encouraging initial Phase 2 data of BDTX-1535 in patients with recurrent EGFRm NSCLC with a broad spectrum of classical, non-classical, ...

Starlight Therapeutics, a wholly-owned subsidiary of Lantern Pharmaceuticals , formed to develop transformative CNS cancer treatments with AI-powered innovation, announced today the formation of a ...

The ROS-1 NSCLC current market is mainly dominated by tyrosine kinase inhibitors such as XALKORI at present and is ...

Your local merchants are the same ones who support your local sports teams, fundraisers and church events, along with paying ...

A recent study offering a comprehensive view of the genome and transcriptome of gastrointestinal stromal tumors (GISTs) has ...

A recent study offering a comprehensive view of the genome and transcriptome of gastrointestinal stromal tumors (GISTs) has introduced a new, multi-omics-based molecular classification of these tumors ...

A new study by researchers at AIIMS Bhubaneswar on Monday showed a ‘hidden’ form of leprosy can silently affect the brain and spinal cord. While leprosy is an ancient disease that often leads ...